Sequential intravesical gemcitabine/docetaxel provides a durable remission in recurrent high-risk NMIBC following BCG therapy.
暂无分享，去创建一个
A. Kibel | M. Preston | G. Steele | K. Mouw | K. Salari | M. Mossanen | M. O'Donnell | A. Feldman | Affan Zafar | Matthew W. Wszolek | Kendrick Yim | Kevin Melnick | Sarah L. Mott | Filipe L.F. Carvalho | Timothy N. Clinton | Graeme S. Steele | Michelle Hirsch | Natalie Rizzo | Chin-Lee Wu